Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Interactive Cardiovascular and Thoracic Surgery|April 3, 2020
Neck cannulation for bypass in redo sternotomy in children and adults with congenital heart diseaseMuhammad R Mustafa, Ralph M L Neijenhuis, Barbara Furci, et al.The Journal of Thoracic and Cardiovascular Surgery|December 9, 2020
Cone reconstruction for Ebstein anomaly: Late biventricular function and possible remodelingRalph M L Neijenhuis, Victor T Tsang, Jan Marek, et al.Frontiers in Cardiovascular Medicine|July 12, 2023
The potential of sodium-glucose cotransporter 2 inhibitors for the treatment of systemic right ventricular failure in adults with congenital heart diseaseRalph M L Neijenhuis, Marieke Nederend, Monique R M Jongbloed, et al.Open Heart|January 30, 2025
Sacubitril/valsartan is associated with improvements in quality of life in adult congenital heart disease patients with systemic right ventricular failureRalph M L Neijenhuis, Marieke Nederend, Anna E van Groningen, et al.Journal of Cardiovascular Development and Disease|March 28, 2023
Contemporary Management Strategies of Baffle Leaks in Adults with a Failing Systemic Right Ventricle Late after Atrial Switch: A Case Series and Literature OverviewRalph M L Neijenhuis, Madelien V Regeer, Frank van der Kley, et al.International Journal of Cardiology. Congenital Heart Disease|July 21, 2025
Echocardiographic effects of sodium-glucose cotransporter 2 inhibitors in single ventricle circulatory failureRalph M L Neijenhuis, Madelien V Regeer, Niki L Walker, et al.Heart Rhythm|January 9, 2026
Effectiveness of Cardiac Resynchronization Therapy in Adult Congenital Heart Disease: A Meta-Analysis of Biventricular and Conduction System Pacing OutcomesBert A C Zwaenepoel, Ralph M L Neijenhuis, Gruschen Veldtman, et al.Journal of the American College of Cardiology|March 26, 2024
Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Congenital Heart DiseaseRalph M L Neijenhuis, Simon T MacDonald, Filip Zemrak, et al.Frontiers in Cardiovascular Medicine|May 25, 2026
Real-world experience with sodium-glucose cotransporter 2 inhibitors in adults with Fontan circulatory failureRalph M L Neijenhuis, Ari M Cedars, Ali Zaidi, et al.Pageof 1